Saruplase

沙芦普酶

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSaruplase
Drug Alias NamePro-urokinase (Grunenthal/Genentech)scuPARescupaseCG-4509
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionUrokinase plasminogen activator stimulants
TargetsUrokinase plasminogen activator
Therapy Area/IndicationsMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesGrunenthal GmbhGenentech Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMyocardial Infarction

Other Information

ATC CodeB01AD08
Related LinksKEGG